Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 2 1

Status

Active not recruiting 2Completed 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 3Other 1Gastrointestinal 1

Conditions

Breast Neoplasms 2Osteoporosis 1Myocardial Ischemia 1Heart Diseases 1Estrogen Receptor Positive Breast Cancer 1Coronary Disease 1Colonic Neoplasms 1Cardiovascular Diseases 1Bone Diseases 1

Interventions

Trastuzumab 732Paclitaxel 695Cyclophosphamide 647Docetaxel 560Capecitabine 485Letrozole 437Fulvestrant 400Carboplatin 398Doxorubicin 341Tamoxifen 308Anastrozole 279pembrolizumab 274exemestane 258Epirubicin 251pertuzumab 240Radiotherapy 239palbociclib 224Bevacizumab 222Gemcitabine 215Vinorelbine 197Lapatinib 181130-nm albumin-bound paclitaxel 172Magnetic Resonance Spectroscopy 164Albumin-Bound Paclitaxel 157eribulin 154Surveys and Questionnaires 151Exercise 151Drug Therapy 141Taxes 134Fluorouracil 133

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Estrogens × Breast × Clear all
NCT05562518 2026-04-30

GRACE

University Hospital, Ghent

Phase 4 Active not recruiting
160 enrolled
Breast

Breast Neoplasms

NCT02238808 2025-06-26

PRESTO

AHS Cancer Control Alberta

Phase 2 Active not recruiting
19 enrolled
Breast

Estrogen Receptor Positive Breast Cancer

NCT00000611 2016-04-15

Women's Health Initiative (WHI)

National Heart, Lung, and Blood Institute (NHLBI)

Phase 3 Completed
BreastGastrointestinal

Bone Diseases, Breast Neoplasms, Cardiovascular Diseases, Colonic Neoplasms, Coronary Disease, Heart Diseases, Osteoporosis, Myocardial Ischemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡